FDA describes legal limits of drug compounding

被引：0

|

作者：

不详

机构：

来源：

AMERICAN JOURNAL OF VETERINARY RESEARCH | 2020年 / 81卷 / 02期

关键词：

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

引用

收藏

页码：99 / 99

页数：1

相关论文

共 50 条

[41] FDA continues work in identifying substances appropriate for compounding
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (15) : 1258 - 1259
[42] FDA inspections find unsafe practices in compounding pharmacies
McCarthy, Michael
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[43] FDA eyes regulating sterile-product compounding
Thompson, CA
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (17) : 1562 - +
[44] LEGAL LIMITS
Dolin, Kieran
UNIVERSITY OF WESTERN AUSTRALIA LAW REVIEW, 2015, 39 (02): : 469 - 474
[45] LEGAL LIMITS
MARTIN, K
NEW STATESMAN & SOCIETY, 1993, 6 (247): : 27 - 27
[46] THE OUTER LIMITS OF FDA INSPECTIONS
SCARLETT, T
JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY, 1991, 45 (04): : 204 - 208
[47] Considering robotics for drug compounding
Markarian, Jennifer
Pharmaceutical Technology, 2021, 45 (06) : 26 - 28
[48] THE FDA LIMITS THE DOSAGE OF SIMVASTATIN
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2011, 111 (10) : 22 - 23
[49] Drug compounding for veterinary patients
Papich M.G.
The AAPS Journal, 7 (2)
[50] Drug compounding for veterinary patients
Papich, MG
AAPS JOURNAL, 2005, 7 (02):

← 1 2 3 4 5 →